Retraction Note: High levels of long non-coding RNA DICER1-AS1 are associated with poor clinical prognosis in patients with osteosarcoma.

IF 3.3 4区 医学 Q1 Medicine
X-H Hu, J Dai, H-L Shang, Z-X Zhao, Y-D Hao
{"title":"Retraction Note: High levels of long non-coding RNA DICER1-AS1 are associated with poor clinical prognosis in patients with osteosarcoma.","authors":"X-H Hu, J Dai, H-L Shang, Z-X Zhao, Y-D Hao","doi":"10.26355/eurrev_202505_37231","DOIUrl":null,"url":null,"abstract":"<p><p>The article \"High levels of long non-coding RNA DICER1-AS1 are associated with poor clinical prognosis in patients with osteosarcoma\" by X.-H. Hu, J. Dai, H.-L. Shang, Z.-X. Zhao, Y.-D. Hao, published in Eur Rev Med Pharmacol Sci 2018; 22 (22): 7640-7645-DOI: 10.26355/eurrev_201811_16379-PMID: 30536305 has been retracted in accordance with the Publisher and the Editor in Chief. Following some concerns raised on PubPeer (link: https://pubpeer.com/publications/2F91E52E0FA92A70237B1ECA287AF6), the Editor in Chief has started an investigation to assess the validity of the concerns raised. The journal's investigation identified that authors used primers specific to mouse genes for clinical samples, revealing ethical misconduct and data fabrication. The Editorial Team has contacted the authors to inform them of the ongoing investigation and to request the original data supporting the manuscript; however, the authors have not responded to these communications. Consequently, the Editor in Chief has decided to retract the article. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/16379.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"29 5","pages":"223"},"PeriodicalIF":3.3000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European review for medical and pharmacological sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.26355/eurrev_202505_37231","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

The article "High levels of long non-coding RNA DICER1-AS1 are associated with poor clinical prognosis in patients with osteosarcoma" by X.-H. Hu, J. Dai, H.-L. Shang, Z.-X. Zhao, Y.-D. Hao, published in Eur Rev Med Pharmacol Sci 2018; 22 (22): 7640-7645-DOI: 10.26355/eurrev_201811_16379-PMID: 30536305 has been retracted in accordance with the Publisher and the Editor in Chief. Following some concerns raised on PubPeer (link: https://pubpeer.com/publications/2F91E52E0FA92A70237B1ECA287AF6), the Editor in Chief has started an investigation to assess the validity of the concerns raised. The journal's investigation identified that authors used primers specific to mouse genes for clinical samples, revealing ethical misconduct and data fabrication. The Editorial Team has contacted the authors to inform them of the ongoing investigation and to request the original data supporting the manuscript; however, the authors have not responded to these communications. Consequently, the Editor in Chief has decided to retract the article. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/16379.

注:高水平的长链非编码RNA DICER1-AS1与骨肉瘤患者临床预后不良相关。
文章《高水平的长链非编码RNA DICER1-AS1与骨肉瘤患者临床预后不良相关》,作者X.-H。胡、代、洪、利。商,Z.-X。赵,Y.-D。Hao,发表于Eur Rev Med Pharmacol Sci 2018;22 (22): 7640-7645-DOI: 10.26355/eurrev_201811_16379-PMID: 30536305已根据出版商和主编的要求撤回。在PubPeer(链接:https://pubpeer.com/publications/2F91E52E0FA92A70237B1ECA287AF6)上提出了一些担忧之后,总编辑开始了一项调查,以评估所提出的担忧的有效性。该杂志的调查发现,作者在临床样本中使用了特定于小鼠基因的引物,这暴露了道德不端和数据伪造。编辑团队已经联系了作者,告知他们正在进行的调查,并要求他们提供支持稿件的原始数据;然而,作者没有对这些来文作出回应。因此,总编辑决定撤回这篇文章。这篇文章已被撤回。对于由此造成的任何不便,出版商深表歉意。https://www.europeanreview.org/article/16379。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.30
自引率
6.10%
发文量
906
审稿时长
2-4 weeks
期刊介绍: European Review for Medical and Pharmacological Sciences, a fortnightly journal, acts as an information exchange tool on several aspects of medical and pharmacological sciences. It publishes reviews, original articles, and results from original research. The purposes of the Journal are to encourage interdisciplinary discussions and to contribute to the advancement of medicine. European Review for Medical and Pharmacological Sciences includes: -Editorials- Reviews- Original articles- Trials- Brief communications- Case reports (only if of particular interest and accompanied by a short review)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信